 NEW YORK, March 02, 2022 GLOBE NEWSWIRE -- Protara Therapeutics, Inc. Nasdaq: TARA, a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in fireside chats at two upcoming virtual conferences: 